CRVO
CervoMed Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.56
+0.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 56.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.69x
- Price / sales
- 119.99x
- Price / cash flow
- -1.38x
Enterprise value
- Enterprise value
- $13.8M
- EV / sales
- 42.68x
- EV / EBITDA
- -0.45x
- EV / EBIT
- -0.44x
- Market cap
- $38.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026